Skip to main content

Table 1 Characteristics of the patients who underwent laparoscopic gynaecologic surgery and antiemetic therapy with either 0.075 mg of palonosetron (group P) or 40 mg of aprepitant (group A)

From: Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial

 

Group P (n = 47)

Group A (n = 46)

Operative time, minutes (mean ± SD)

79.2 ± 42.2

71.5 ± 37.7

Age, years (mean ± SD)

37.6 ± 8.0

37.9 ± 11.1

Height, cm (mean ± SD)

159.6 ± 5.1

160.5 ± 5.4

Weight, kg (mean ± SD)

54.8 ± 5.8

56.2 ± 5.6

  1. The data are expressed as mean ± SD.
  2. No significant differences were observed between groups P and A.